The adverse events of CDK4/6 inhibitors for HR+/ HER2- breast cancer: an umbrella review of meta-analyses of randomized controlled trials

• Main Authors: Dongqing Pu (Author), Yue Wu (Author), Debo Xu (Author), Guangxi Shi (Author), Hanhan Chen (Author), Dandan Feng (Author), Mengdi Zhang (Author), Jingwei Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The clinical selection of three CDK4/6 inhibitors presents a challenging issue, owing to the absence of distinct clinical case characteristics, biomarkers, and their comparable clinical benefits in progression-free survival and overall survival To inform clinical treatment decisions, we...